For research and educational purposes only. Not medical advice.
PF-06260414 Reference
Educational, not medical advice reference for PF-06260414: SARM; regulatory status, evidence posture, source review, and schedule notes. Also known as PF0626…
Reference summary
A first-in-human safety, pharmacokinetic, and pharmacodynamic study exists. It did not establish an approved indication or a validated body-composition program.
- Categories
- SARM
- Aliases
- PF06260414, Pfizer SARM, Non-steroidal SARM
- Evidence posture
- human — Human safety / PK work exists, but no approved product followed. ALT changes were reported in the published safety work. WADA-prohibited; no FDA approval and no validated gym-use program.
- Regulatory status
- No FDA-approved PF-06260414 drug label. FDA consumer warnings against SARMs sold in bodybuilding products apply to the class. WADA prohibits SARMs under category S1.2 anabolic agents at all times.
- Content review status
- research reference
Selected public sources
- FDA consumer update: SARMs are not FDA-approved and cannot be legally marketed as dietary supplements
- WADA prohibited list: SARMs are category S1.2 anabolic agents prohibited at all times
- PubMed: PF-06260414 first-in-human safety, PK, and PD study
- PubMed: PF-06260414 / TFM-4AS-1 SARM metabolism study for doping control